The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).

Fact checked by Jennifer Klump About the Author Huma Sheikh, MD, is a neurologist who specializes in migraine and stroke. She ...

The Institute for Public Strategies holds a guided discussion and screens ABC7’s documentary Injecting Hope to explore the ...